University of California San Francisco
Give to UCSF
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
New guidelines recommending screening mammography every two years for women ages 50 to 74 would save the United States $4.3 billion a year in health care costs, according to a UCSF-led study.
UCSF Medical Center will name its new women’s hospital at Mission Bay in honor of Betty Irene Moore, a patient safety pioneer and advocate.
The funding will allow the UCSF team to continue to pursue development of the Smart Diaphragm, a wireless monitoring and warning system for early signs of preterm birth.
UCSF researchers have shown that, in mice at least, pregnancy complications after fetal surgery are triggered by activation of the mother’s T cells.
Someone with access to firearms is three times more likely to commit suicide and nearly twice as likely to be the victim of a homicide as someone who does not have access, according to a UCSF analysis.
Women giving birth in California can face a huge cost difference in their hospital bills, according to a new UCSF study that highlights the need for more price transparency in health care.
A collaborative model of maternity care between UCSF’s certified nurse-midwives and obstetricians that began at San Francisco General Hospital almost 40 years ago allows each to learn from one another and practice to their unique strengths.
UCSF faculty members are collaborating with Birth Justice Project co-founders and a volunteer doula program director at San Francisco General Hospital for a vocational training program.
Women's reproductive health experts Diana Taylor and Tracy Weitz conducted the foundational research on the safety and quality of aspiration abortions that now has become law of the land in California.
Childbirth is not a major contributor to sexual dysfunction in women later in life, according to a new study led by UCSF researchers.
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.
Claire Brindis, director of the UCSF Philip R. Lee Institute for Health Policy Studies, discusses the changes to health coverage under the Affordable Care Act for women and young adults.
A class of flame retardants that has been linked to learning difficulties in children has rapidly declined in pregnant women’s blood since the chemicals were banned in California a decade ago, according to a study led by researchers at UCSF.
